External reports (aggregated public sources), Value Investors Club

Value Investors Club

Value Investors Club (.com) is an exclusive online investment club where top investors share their best ideas. Content available at the above link/PDF preview is an external article authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External reports (aggregated public sources)

Equity Bottom-Up

SELLAS Life Sciences Group / Equity Bottom-Up

<ul><li>Author recommends going long on SELLAS Life Sciences (SLS) for significant upside potential</li><li>Current price of around $1.4 per share with a 1-year target price of $43 per share, projecting a 30x upside</li><li>SLS is expected to have a hard catalyst in the coming weeks, reducing science risk and offering more potential compared to previous investments in other companies</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Author recommends going long on SELLAS Life Sciences (SLS) for significant upside potentialCurrent price of around $1.4 per share with a 1-year target price of $43 per share, projecting a 30x upsideSLS is expected to have a hard catalyst in the coming weeks, reducing science risk and offering more potential compared to previous investments in other companiesThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Sellas Life Sciences Group I (SLS) - Thursday, Jun 13, 2024